288 related articles for article (PubMed ID: 29872625)
21. Enhanced Antiglioma Efficacy of Ultrahigh Loading Capacity Paclitaxel Prodrug Conjugate Self-Assembled Targeted Nanoparticles.
Jiang Y; Wang X; Liu X; Lv W; Zhang H; Zhang M; Li X; Xin H; Xu Q
ACS Appl Mater Interfaces; 2017 Jan; 9(1):211-217. PubMed ID: 27976583
[TBL] [Abstract][Full Text] [Related]
22. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
[TBL] [Abstract][Full Text] [Related]
23. Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles.
Esfandyari-Manesh M; Mostafavi SH; Majidi RF; Koopaei MN; Ravari NS; Amini M; Darvishi B; Ostad SN; Atyabi F; Dinarvand R
Daru; 2015 Apr; 23(1):28. PubMed ID: 25903677
[TBL] [Abstract][Full Text] [Related]
24. Biomimetic Shells Endow Sub-50 nm Nanoparticles with Ultrahigh Paclitaxel Payloads for Specific and Robust Chemotherapy.
Chen X; Ling X; Zhao L; Xiong F; Hollett G; Kang Y; Barrett A; Wu J
ACS Appl Mater Interfaces; 2018 Oct; 10(40):33976-33985. PubMed ID: 30203956
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the cytotoxic effects, cellular uptake and cellular distribution of paclitaxel-loaded nanoparticles in glioblastoma cells
Wang L; Liu C; Qiao F; Li M; Xin H; Chen N; Wu Y; Liu J
Exp Ther Med; 2021 Apr; 21(4):292. PubMed ID: 33717235
[TBL] [Abstract][Full Text] [Related]
26. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
27. Polysorbate 80-coated albumin nanoparticles to deliver paclitaxel into the brain to treat glioma.
Vishwanath K; Wilson B; Geetha KM; Murugan V
Ther Deliv; 2023 Mar; 14(3):193-206. PubMed ID: 37291872
[No Abstract] [Full Text] [Related]
28. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.
Xing L; Shi Q; Zheng K; Shen M; Ma J; Li F; Liu Y; Lin L; Tu W; Duan Y; Du L
Theranostics; 2016; 6(10):1573-87. PubMed ID: 27446491
[TBL] [Abstract][Full Text] [Related]
29. An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy.
Zhao Y; Cai C; Liu M; Zhao Y; Pei W; Chu X; Zhang H; Wang Z; Han J
Colloids Surf B Biointerfaces; 2019 Nov; 183():110394. PubMed ID: 31398618
[TBL] [Abstract][Full Text] [Related]
30. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel.
Yang X; Cai X; Yu A; Xi Y; Zhai G
J Colloid Interface Sci; 2017 Jun; 496():311-326. PubMed ID: 28237749
[TBL] [Abstract][Full Text] [Related]
31. Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel.
Yin T; Cai H; Liu J; Cui B; Wang L; Yin L; Zhou J; Huo M
Eur J Pharm Sci; 2016 Feb; 83():79-87. PubMed ID: 26699227
[TBL] [Abstract][Full Text] [Related]
32. Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Chen D
J Drug Target; 2015 May; 23(4):311-22. PubMed ID: 25539074
[TBL] [Abstract][Full Text] [Related]
33. Self-Assembled nanoparticles of natural bioactive molecules enhance the delivery and efficacy of paclitaxel in glioblastoma.
Li Y; Zhao Q; Zhu X; Zhou L; Song P; Liu B; Tian D; Chen Q; Zhou J; Deng G
CNS Neurosci Ther; 2024 Apr; 30(4):e14528. PubMed ID: 38044793
[TBL] [Abstract][Full Text] [Related]
34. D-T7 Peptide-Modified PEGylated Bilirubin Nanoparticles Loaded with Cediranib and Paclitaxel for Antiangiogenesis and Chemotherapy of Glioma.
Yu M; Su D; Yang Y; Qin L; Hu C; Liu R; Zhou Y; Yang C; Yang X; Wang G; Gao H
ACS Appl Mater Interfaces; 2019 Jan; 11(1):176-186. PubMed ID: 30525386
[TBL] [Abstract][Full Text] [Related]
35. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.
Sandbhor P; Goda J; Mohanty B; Gera P; Yadav S; Chekuri G; Chaudhari P; Dutt S; Banerjee R
Drug Deliv Transl Res; 2023 Feb; 13(2):608-626. PubMed ID: 36245060
[TBL] [Abstract][Full Text] [Related]
36. A comparative in vitro evaluation of self-assembled PTX-PLA and PTX-MPEG-PLA nanoparticles.
Cui F; Li Y; Zhou S; Jia M; Yang X; Yu F; Ye S; Hou Z; Xie L
Nanoscale Res Lett; 2013 Jun; 8(1):301. PubMed ID: 23806106
[TBL] [Abstract][Full Text] [Related]
37. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
[TBL] [Abstract][Full Text] [Related]
38.
Yousefi Aldashi S; Saffari Z; Ebrahimi Shahmabadi H; Akbarzadeh A
Adv Pharm Bull; 2021 Feb; 11(2):267-273. PubMed ID: 33880348
[No Abstract] [Full Text] [Related]
39. RGD-decorated redox-responsive d-α-tocopherol polyethylene glycol succinate-poly(lactide) nanoparticles for targeted drug delivery.
Guo Y; Niu B; Song Q; Zhao Y; Bao Y; Tan S; Si L; Zhang Z
J Mater Chem B; 2016 Apr; 4(13):2338-2350. PubMed ID: 32263229
[TBL] [Abstract][Full Text] [Related]
40. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
